Purpose: The aim of this study is to assess multi-center reproducibility and longitudinal consistency of MRI imaging measurements, as part of a phase III longitudinal multi-center study comparing the neurotoxic effect following prophylactic cranial irradiation with hippocampal avoidance (HA-PCI), in comparison with conventional PCI in patients with small-cell lung cancer.

Methods: Harmonized MRI acquisition protocols from six participating sites and two different vendors were compared using both physical and human phantoms. We assessed variability across sites and time points by evaluating various phantoms and data including hippocampal volume, diffusion metrics, and resting-state fMRI, from two healthy volunteers.

Results: We report average coefficients of variation (CV) below 5% for intrascanner, intravendor, and intervendor reproducibility for both structural and diffusion imaging metrics, except for diffusion metrics obtained from tractography with average CVs ranging up to 7.8%. Additionally, resting-state fMRI showed stable temporal SNR and reliable generation of subjects DMN across vendors and time points.

Conclusion: These findings indicate that the presented multi-site MRI acquisition protocol can be used in a longitudinal study design and that pooling of the acquired data as part of the phase III longitudinal HA-PCI project is possible with careful monitoring of the results of the half-yearly QA assessment to follow-up on potential scanner-related longitudinal changes in image quality.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00234-018-2017-1DOI Listing

Publication Analysis

Top Keywords

multi-center reproducibility
8
reproducibility structural
8
structural diffusion
8
phase iii
8
iii longitudinal
8
mri acquisition
8
diffusion metrics
8
resting-state fmri
8
longitudinal
5
diffusion
4

Similar Publications

The foundation model, trained on extensive and diverse datasets, has shown strong performance across numerous downstream tasks. Nevertheless, its application in the medical domain is significantly hindered by issues such as data volume, heterogeneity, and privacy concerns. Therefore, we propose the Vision Foundation Model General Lightweight (VFMGL) framework, which facilitates the decentralized construction of expert clinical models for various medical tasks.

View Article and Find Full Text PDF

The drug development process in psychiatry faces significant challenges due to low reproducibility rates in animal testing, which often leads to translation failures. To address this issue, we introduce a new approach in psychiatric drug development: a preclinical randomized controlled trial (preRCT). To demonstrate its potential utility, we conducted a multi-center preRCT using the alcohol deprivation effect (ADE) model to assess the impact of ketamine and R-ketamine on alcohol relapse across three European research centers.

View Article and Find Full Text PDF

Hyperpolarized (HP) gas pulmonary MR ventilation images are typically quantified using ventilation defect percent (VDP); however, the test-retest variability of VDP has not been systematically established in multi-center trials. Herein, we perform a systematic review of the test-retest literature on the variability of VDP, and similar metrics, generated from HP MRI. This review utilizes the Medline, EMBASE, and EBM Reviews databases and includes studies that assessed the variability of HP MRI VDP.

View Article and Find Full Text PDF

: Radiomics has become a valuable tool in medical imaging, but its clinical use is limited by data variability and a lack of reproducibility between centers. This study aims to assess the differences between two scanners and provide guidance on image acquisition methods to reduce variations between images obtained from different centers. : This study utilized medical images obtained in two different imaging centers, with two different 3T MRI scanners.

View Article and Find Full Text PDF

Background: With fatal malignant peculiarities and poor survival rate, outcomes of pancreatic adenocarcinoma (PAAD) were frustrated by non-response and even resistance to therapy due to heterogeneity across clinical patients. Nevertheless, pharmacogenomics has been developed for individualized-treatment and still maintains obscure in PAAD.

Methods: A total of 964 samples from 10 independent multi-center cohorts were enrolled in our study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!